Dark Spot

Study Number: C25-EP148

Study Location: 

Phoenix Research Center: 2421 W. Peoria Ave, Suite 110 Phoenix, Arizona 85029
Compensation: Up to $600.00

Gender:

Male and Female

Age:

18-65 Years Old

Skin Type:

Fitz I-VI

Study Description:

This clinical trial evaluates the effectiveness and tolerability of the Sponsor’s facial product over 12 weeks of use, followed by an 8-week regression period, in men and women with at least one facial dark spot (≥3 mm, moderate intensity) and moderate overall facial hyperpigmentation.

Study Requirements:

Must:

  • Have at least 1 dark spot 3mm in diameter

Cannot:

  • Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn’s disease, HIV, or rheumatoid arthritis).

 

Pre-Study Instructions Section:

Visit 1 Instructions

  • Avoid application of any topical products to the face for at least 2 days prior to visit 1.
  • Bring a valid ID or passport.
  • If you are not able to make your appointment, please contact us ASAP by calling us at 833-530-7596.

Complete the prescreening survey below:

All information you provide will be kept confidential, you may be contacted by telephone or text, and your information may be added to a database.

Screening Survey

Privacy Policy

CCPA